© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 23, 2022
The BLA was supported by positive data from 54 patients with hemophilia B in the pivotal phase 3 HOPE-B trial.
August 17, 2022
“The approval of ZYNTEGLO marks a watershed moment for the field of gene therapy," Andrew Obenshain, CEO of Bluebird Bio says.
February 28, 2022
Clinical and industry leaders share their perspectives on the importance of collaboration in developing treatments for rare diseases.
January 28, 2022
A multitude of promising new investigative therapies are on the horizon for inherited retinal disease.
Atopic Dermatitis Severity Linked to Incremental Societal Healthcare Costs
Strong Response Maintenance for Plaque Psoriasis Patients Using Tildrakizumab
Clinical Efficacy, Safety of Brolucizumab Similar to Trial Results for nAMD Patients